Description: Eden Research plc is a technology development and commercialization company. The Company focuses on plant protection, animal and human health, and biocides. The Company's segments include Biocides, Human health and Agrochemicals. It offers a range of product categories, such as Foliar Diseases Control, including Botrytis, Botrytis Trail Data and Powdery Mildew; Soil Pest, including Nematodes and New Nematode Data; Protected Glass House Crops, including Spider Mites, Spider Mite Trail Data, Whitefly, Whitefly Trail Data and Powdery Mildew; Vascular Diseases Control, including Esca, Eutypa and Pierce's Diseases, and Post-Harvest Applications. Its encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.
Home Page: www.edenresearch.com
EDEN Technical Analysis
67C Innovation Drive
Abingdon,
OX14 4RQ
United Kingdom
Phone:
44 12 8535 9555
Officers
| Name | Title |
|---|---|
| Mr. Sean M. Smith | CEO & Exec. Director |
| Mr. Alexander John Abrey | CFO, Sec. & Exec. Director |
| Dr. Aoife Dillon | Global Head of Biology & Devel. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.8254 |
| Price-to-Sales TTM: | 16.0475 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 16 |